liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
The Use of Central Nervous System Active Drugs During Pregnancy
Tornblad Institute, Lund Univeraity, Sweden.
Department of Statistics, Monitoring and Analyses, National Board of Health and Welfare, Sweden.
Linköping University, Department of Medical and Health Sciences, Division of Drug Research. Linköping University, Faculty of Health Sciences.ORCID iD: 0000-0002-6041-074
2013 (English)In: Pharmaceuticals, ISSN 1424-8247, E-ISSN 1424-8247, Vol. 6, no 10, 1221-1286 p.Article, review/survey (Refereed) Published
Abstract [en]

CNS-active drugs are used relatively often during pregnancy. Use during early pregnancy may increase the risk of a congenital malformation; use during the later part of pregnancy may be associated with preterm birth, intrauterine growth disturbances and neonatal morbidity. There is also a possibility that drug exposure can affect brain development with long-term neuropsychological harm as a result. This paper summarizes the literature on such drugs used during pregnancy: opioids, anticonvulsants, drugs used for Parkinson’s disease, neuroleptics, sedatives and hypnotics, antidepressants, psychostimulants, and some other CNS-active drugs. In addition to an overview of the literature, data from the Swedish Medical Birth Register (1996–2011) are presented. The exposure data are either based on midwife interviews towards the end of the first trimester or on linkage with a prescribed drug register. An association between malformations and maternal use of anticonvulsants and notably valproic acid is well known from the literature and also demonstrated in the present study. Some other associations between drug exposure and outcome were found.

Place, publisher, year, edition, pages
2013. Vol. 6, no 10, 1221-1286 p.
Keyword [en]
CNS active drugs; opioids; sedatives; hypnotics; antidepressants; psychostimulants; congenital malformations; neonatal morbidity
National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:liu:diva-100125DOI: 10.3390/ph6101221OAI: oai:DiVA.org:liu-100125DiVA: diva2:659879
Available from: 2013-10-28 Created: 2013-10-28 Last updated: 2017-10-22

Open Access in DiVA

fulltext(422 kB)649 downloads
File information
File name FULLTEXT01.pdfFile size 422 kBChecksum SHA-512
660561d992acce36e323e90980d1a485d9bf6137fec1d6e2ccd2f0c458d6efadec604d5438b7f1296a51b32043ca10858e6a6df0dc1a8ee22bf529b77fa6d310
Type fulltextMimetype application/pdf

Other links

Publisher's full text

Authority records BETA

Reis, Margareta

Search in DiVA

By author/editor
Reis, Margareta
By organisation
Division of Drug ResearchFaculty of Health Sciences
In the same journal
Pharmaceuticals
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
Total: 649 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 80 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf